English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Preterm infants are susceptible to opportunistic infection because of their immature immune system. With regard to fungal infection, Aspergillosis is second only to Candida infection in these patients. Here we report the case of an extremely low birth weight (ELBW) infant who developed pulmonary Aspergillosis and was successfully treated by micafungin (echinocandins). The infection occurred in the cavity in chronic lung disease and was diagnosed by typical CT imaging and detection of Aspergillus galactmannan antigen in the serum specimen. To our knowledge, this is the first report of pulmonary Aspergillosis treated with micafungin in ELBW infants

A case of neonatal pulmonary Aspergillosis successfully treated with micafungin